Letters to the Editor
Inflammatory Bowel Disease in Sickle Cell Disease
Diagnostic and Treatment Challenges
Justin M. Azar,
Justin M. Azar
Children's National Health System, Washington, DC
Search for more papers by this author Deepika S. Darbari,
Deepika S. Darbari
Children's National Health System, Washington, DC
Search for more papers by this author Emily R. Meier,
Emily R. Meier
Children's National Health System, Washington, DC
Search for more papers by this author Laurie S. Conklin,
Laurie S. Conklin
Children's National Health System, Washington, DC
Search for more papers by this author Anil Darbari,
Anil Darbari
Children's National Health System, Washington, DC
Search for more papers by this author
Justin M. Azar,
Justin M. Azar
Children's National Health System, Washington, DC
Search for more papers by this author Deepika S. Darbari,
Deepika S. Darbari
Children's National Health System, Washington, DC
Search for more papers by this author Emily R. Meier,
Emily R. Meier
Children's National Health System, Washington, DC
Search for more papers by this author Laurie S. Conklin,
Laurie S. Conklin
Children's National Health System, Washington, DC
Search for more papers by this author Anil Darbari,
Anil Darbari
Children's National Health System, Washington, DC
Search for more papers by this author
First published: 01 November 2014
No abstract is available for this article.
REFERENCE
- 1Darbari DS, Castro O, Taylor JG 6th, et al. Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease. J Natl Med Assoc 2008; 100: 948–951.